These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20332141)
1. Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience. Jackson C; Sirohi B; Cunningham D; Horwich A; Thomas K; Wotherspoon A Ann Oncol; 2010 Oct; 21(10):2061-2068. PubMed ID: 20332141 [TBL] [Abstract][Full Text] [Related]
2. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era. King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755 [TBL] [Abstract][Full Text] [Related]
3. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266 [TBL] [Abstract][Full Text] [Related]
4. Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation. Calvo-Villas JM; Martín A; Conde E; Pascual A; Heras I; Varela R; de la Rubia J; Ramirez MJ; Díez-Martín JL; Panizo C; Rodríguez-Salazar MJ; Pascual MJ; Donato EM; González-Barca E; Caballero MD; Ann Oncol; 2010 Sep; 21(9):1891-1897. PubMed ID: 20231299 [TBL] [Abstract][Full Text] [Related]
6. The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant. Furlan C; Matrone F; Rupolo M; Ciancia R; Zanet E; Montante B; Palazzari E; Navarria F; Trovo M; Bulian P; Spina M; Coassin E; Mascarin M; De Paoli A; Franchin G; Michieli M Cancer Radiother; 2019 Sep; 23(5):378-384. PubMed ID: 31178272 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475 [TBL] [Abstract][Full Text] [Related]
8. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Ekstrand BC; Lucas JB; Horwitz SM; Fan Z; Breslin S; Hoppe RT; Natkunam Y; Bartlett NL; Horning SJ Blood; 2003 Jun; 101(11):4285-9. PubMed ID: 12586628 [TBL] [Abstract][Full Text] [Related]
10. Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma. Hertzberg MS; Crombie C; Benson W; Taper J; Gottlieb D; Bradstock KF Ann Oncol; 2006 May; 17 Suppl 4():iv25-30. PubMed ID: 16702181 [TBL] [Abstract][Full Text] [Related]
11. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207 [TBL] [Abstract][Full Text] [Related]
12. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Biasoli I; Stamatoullas A; Meignin V; Delmer A; Reman O; Morschhauser F; Coiffier B; Bosly A; Diviné M; Brice P Cancer; 2010 Feb; 116(3):631-9. PubMed ID: 20029973 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
14. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease. Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535 [TBL] [Abstract][Full Text] [Related]
15. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience. Viviani S; Di Nicola M; Bonfante V; Di Stasi A; Carlo-Stella C; Matteucci P; Magni M; Devizzi L; Valagussa P; Gianni AM Leuk Lymphoma; 2010 Jul; 51(7):1251-9. PubMed ID: 20528244 [TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Chera BS; Olivier K; Morris CG; Lynch JW; Mendenhall NP Am J Clin Oncol; 2007 Dec; 30(6):601-6. PubMed ID: 18091054 [TBL] [Abstract][Full Text] [Related]
18. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network. Farrell K; McKay P; Leach M Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507 [TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO Leuk Lymphoma; 2004 Aug; 45(8):1551-7. PubMed ID: 15370206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]